Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACVRL1,Serine/threonine-protein kinase receptor R3,27700,130,2.82 [1.58-5.02],0.0004511848546464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADA2,Adenosine deaminase 2,27757,131,2.14 [1.54-2.96],5.14593163490015e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,23581,108,1.64 [1.24-2.16],0.0004483345634334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24177,111,2.36 [1.50-3.70],0.0001986941844352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,27812,130,1.64 [1.13-2.38],0.0098675063287751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTSL2,ADAMTS-like protein 2,24262,111,2.10 [1.33-3.33],0.0015159731429331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRE1,Adhesion G protein-coupled receptor E1,24177,111,1.58 [1.16-2.14],0.0034687099729331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRG1,Adhesion G-protein coupled receptor G1,27812,130,1.34 [1.11-1.62],0.0024732863227098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADM,Pro-adrenomedullin,28189,131,2.71 [1.51-4.85],0.00082359252376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGER,Advanced glycosylation end product-specific receptor,27869,131,1.72 [1.19-2.47],0.0035026670998134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGRN,Agrin,28061,132,1.77 [1.21-2.61],0.0035349891238896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALCAM,CD166 antigen,28281,131,3.56 [1.74-7.31],0.0005284438169533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMBP,Protein AMBP,28153,131,3.83 [1.82-8.04],0.0003964994785497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMIGO2,Amphoterin-induced protein 2,27812,130,3.00 [1.60-5.60],0.0005880191916324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA10,Annexin A10,27277,126,1.37 [1.17-1.61],0.000143691721819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APLP1,Amyloid-like protein 1,27938,130,0.61 [0.45-0.83],0.001832906051123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOA1,Apolipoprotein A-I,24305,112,0.34 [0.16-0.73],0.0054716667929129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AREG,Amphiregulin,27812,130,1.82 [1.39-2.39],1.242789603808258e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASGR1,Asialoglycoprotein receptor 1,27748,130,1.95 [1.21-3.14],0.0059444852701144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATRAID,All-trans retinoic acid-induced differentiation factor,24177,111,1.60 [1.28-2.01],3.847377710776225e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B2M,Beta-2-microglobulin,24305,112,1.57 [1.21-2.02],0.0005653935392951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",23595,112,2.07 [1.28-3.37],0.0031356497647588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B4GALT1,"Beta-1,4-galactosyltransferase 1",28061,132,2.26 [1.36-3.77],0.0016937671083501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,27252,129,1.42 [1.15-1.76],0.0009818748377781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAMBI,BMP and activin membrane-bound inhibitor homolog,27252,129,2.02 [1.37-2.97],0.0003982644167385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCAN,Brevican core protein,27748,130,0.47 [0.30-0.73],0.0008844670149748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BGLAP,Osteocalcin,24262,111,1.58 [1.29-1.93],1.1297141516632352e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BMPER,BMP-binding endothelial regulator protein,23725,107,2.27 [1.25-4.11],0.0070619177657556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BSG,Basigin,28223,128,4.41 [2.24-8.70],1.7954330607058997e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BST2,Bone marrow stromal antigen 2,28203,133,1.54 [1.25-1.90],5.373368321641501e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTN2A1,Butyrophilin subfamily 2 member A1,28061,132,2.29 [1.35-3.89],0.0021028484072506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTN3A2,Butyrophilin subfamily 3 member A2,27925,130,2.14 [1.61-2.84],1.4728129576108826e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C7,Complement component C7,23734,106,2.60 [1.51-4.47],0.0005349855107828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA12,Carbonic anhydrase 12,27812,130,1.94 [1.36-2.76],0.0002305418260361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA9,Carbonic anhydrase 9,28189,131,1.55 [1.15-2.09],0.0043339619768453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALCA,Calcitonin,27700,130,1.40 [1.13-1.74],0.0018277384240553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALCB,Calcitonin gene-related peptide 2,24203,112,1.68 [1.22-2.31],0.0013720765953413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCDC80,Coiled-coil domain-containing protein 80,27938,130,2.27 [1.52-3.39],6.566245596122877e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL11,Eotaxin,28273,130,1.73 [1.17-2.57],0.0064856133170045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL15,C-C motif chemokine 15,28281,131,1.68 [1.24-2.29],0.0008634605942947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL21,C-C motif chemokine 21,28061,132,1.65 [1.28-2.12],9.258737642027192e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL22,C-C motif chemokine 22,27619,130,1.46 [1.10-1.92],0.0078957770615593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL25,C-C motif chemokine 25,28273,130,1.62 [1.20-2.19],0.0017930437780627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN3,CCN family member 3,28235,131,2.22 [1.53-3.23],2.850096982362968e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN4,CCN family member 4,28189,131,1.91 [1.39-2.63],7.292892282157992e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD14,Monocyte differentiation antigen CD14,27317,128,1.94 [1.38-2.73],0.0001465486096521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD160,CD160 antigen,28273,130,1.55 [1.14-2.12],0.0057614483662033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD163,Scavenger receptor cysteine-rich type 1 protein M130,28016,131,1.63 [1.17-2.27],0.003903630757646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD27,CD27 antigen,28005,132,2.26 [1.65-3.10],4.285006141034801e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD274,Programmed cell death 1 ligand 1,27748,130,1.72 [1.15-2.58],0.0084197530604981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD276,CD276 antigen,27916,132,1.90 [1.23-2.94],0.0038982098251286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD28,T-cell-specific surface glycoprotein CD28,27252,129,1.68 [1.14-2.47],0.0080470152875373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300A,CMRF35-like molecule 8,23725,107,2.21 [1.23-3.97],0.007639109640646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300E,CMRF35-like molecule 2,28100,131,2.56 [1.85-3.55],1.6616723126255436e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300LF,CMRF35-like molecule 1,28189,131,1.56 [1.19-2.05],0.0011798704490678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD302,CD302 antigen,27812,130,2.38 [1.56-3.62],5.106865539257022e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,27812,130,2.34 [1.49-3.67],0.0002204241603856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD4,T-cell surface glycoprotein CD4,27880,130,1.88 [1.45-2.43],1.4194338595499868e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD48,CD48 antigen,28018,132,2.68 [1.65-4.36],7.410163249566114e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD5,T-cell surface glycoprotein CD5,28153,131,2.09 [1.40-3.13],0.0003362029407941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD7,T-cell antigen CD7,23547,108,1.86 [1.32-2.62],0.0003928129110042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD70,CD70 antigen,27925,130,1.70 [1.21-2.40],0.0023479899463887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD72,B-cell differentiation antigen CD72,23725,107,1.76 [1.17-2.64],0.0068157444579355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD74,HLA class II histocompatibility antigen gamma chain,28203,133,2.40 [1.62-3.57],1.406378915526813e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD79B,B-cell antigen receptor complex-associated protein beta chain,28273,130,2.02 [1.50-2.71],3.122958565813328e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD80,T-lymphocyte activation antigen CD80,24272,114,2.51 [1.65-3.81],1.6331409280231203e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD83,CD83 antigen,27925,130,2.55 [1.74-3.74],1.5371946502876386e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD99,CD99 antigen,27929,131,2.82 [1.33-5.99],0.0068306501593083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDCP1,CUB domain-containing protein 1,27748,130,1.91 [1.50-2.43],1.6429650368291497e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH1,Cadherin-1,26977,131,1.55 [1.18-2.04],0.0018215861926366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH2,Cadherin-2,27938,130,2.09 [1.38-3.17],0.0005287758325828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,23825,109,1.77 [1.42-2.22],5.665927648246487e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CGREF1,Cell growth regulator with EF hand domain protein 1,27938,130,1.91 [1.36-2.69],0.000216682050989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24203,112,1.66 [1.16-2.38],0.0057622560538516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHGA,Chromogranin-A,24262,111,1.32 [1.11-1.57],0.0019298933099741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHI3L1,Chitinase-3-like protein 1,27274,130,1.27 [1.06-1.51],0.009119357945449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHRDL1,Chordin-like protein 1,28018,132,2.43 [1.52-3.89],0.0002093605039903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CKAP4,Cytoskeleton-associated protein 4,28126,128,2.73 [1.77-4.20],5.488053856814917e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC14A,C-type lectin domain family 14 member A,27929,131,2.03 [1.27-3.26],0.003152172104507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC4D,C-type lectin domain family 4 member D,27925,130,1.43 [1.13-1.81],0.0027886619939194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC6A,C-type lectin domain family 6 member A,27252,129,1.80 [1.35-2.39],5.891560391154018e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC7A,C-type lectin domain family 7 member A,28273,130,1.82 [1.30-2.55],0.0004704763961426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLGN,Calmegin,23599,110,1.75 [1.24-2.45],0.0013007923445081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLMP,CXADR-like membrane protein,28189,131,2.76 [1.41-5.40],0.0030081363445954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLSTN3,Calsyntenin-3,24203,112,2.01 [1.31-3.07],0.0013142564075015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNDP1,Beta-Ala-His dipeptidase,28016,131,0.66 [0.49-0.90],0.0081520188197896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL18A1,Collagen alpha-1(XVIII) chain,28033,130,2.77 [1.46-5.27],0.0018467982469708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL5A1,Collagen alpha-1(V) chain,23725,107,1.80 [1.27-2.54],0.0008915497114585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL6A3,Collagen alpha-3(VI) chain,28281,131,2.92 [2.06-4.15],1.756818830690024e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COLEC12,Collectin-12,27916,132,3.22 [1.91-5.43],1.2276033658101733e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPXM2,Inactive carboxypeptidase-like protein X2,24272,114,3.10 [1.83-5.24],2.54328041365764e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRHBP,Corticotropin-releasing factor-binding protein,27916,132,2.49 [1.45-4.26],0.0008831706172612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRTAM,Cytotoxic and regulatory T-cell molecule,27748,130,1.54 [1.14-2.09],0.0050495070523713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRYBB2,Beta-crystallin B2,24203,112,1.47 [1.28-1.70],1.0983681283466269e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF1,Macrophage colony-stimulating factor 1,28061,132,2.77 [1.67-4.62],8.514784605146141e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF1R,Macrophage colony-stimulating factor 1 receptor,24295,113,2.01 [1.41-2.88],0.0001287852671411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,27748,130,1.45 [1.16-1.79],0.0008319810954657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CST3,Cystatin-C,27968,131,2.90 [1.84-4.58],4.655838979639767e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSTB,Cystatin-B,27552,126,1.71 [1.23-2.38],0.0012934507488118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSD,Cathepsin D,26055,127,1.89 [1.42-2.51],1.0618842494161263e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSL,Cathepsin L1,27938,130,3.17 [1.81-5.57],5.680103514894846e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSZ,Cathepsin Z,27915,131,2.20 [1.38-3.50],0.0009110388266592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL13,C-X-C motif chemokine 13,28203,133,1.32 [1.09-1.59],0.0042556626938648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL17,C-X-C motif chemokine 17,28273,130,1.51 [1.12-2.03],0.0067199506007144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL9,C-X-C motif chemokine 9,28061,132,1.46 [1.22-1.76],5.287577830060576e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDR1,Epithelial discoidin domain-containing receptor 1,28203,133,2.68 [1.55-4.62],0.0004085632609068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DLL1,Delta-like protein 1,28005,132,2.10 [1.28-3.44],0.003256933749945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DSC2,Desmocollin-2,27591,126,2.08 [1.46-2.96],5.072147193664887e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DSCAM,Down syndrome cell adhesion molecule,24236,113,1.88 [1.17-3.02],0.0085746677312504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DTNB,Dystrobrevin beta,24118,113,1.60 [1.15-2.23],0.0048692527871538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDA2R,Tumor necrosis factor receptor superfamily member 27,28189,131,2.43 [1.71-3.43],5.536622919342118e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDN1,Endothelin-1,23595,112,2.59 [1.51-4.43],0.0005090632855539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFCAB14,EF-hand calcium-binding domain-containing protein 14,24177,111,2.19 [1.57-3.06],4.2596756721676176e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,27963,131,2.08 [1.30-3.32],0.0022207049183779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFNA1,Ephrin-A1,27879,131,2.42 [1.46-4.00],0.0005726212961172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFNA4,Ephrin-A4,27700,130,3.41 [2.30-5.05],9.644364090216612e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ELN,Elastin,24272,114,3.02 [1.91-4.77],2.340656001707862e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPGN,Epigen,24157,113,1.43 [1.15-1.79],0.0013900114800808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHA2,Ephrin type-A receptor 2,26926,129,3.37 [2.46-4.61],3.6095302890847865e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHB4,Ephrin type-B receptor 4,28281,131,2.93 [1.74-4.94],5.215992438130775e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHB6,Ephrin type-B receptor 6,27700,130,2.13 [1.32-3.45],0.0019859748338962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERMAP,Erythroid membrane-associated protein,23581,108,1.66 [1.13-2.44],0.0090780965806932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ESAM,Endothelial cell-selective adhesion molecule,28281,131,1.80 [1.16-2.78],0.0085643831131279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ESM1,Endothelial cell-specific molecule 1,27916,132,1.89 [1.24-2.89],0.0031545503481951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EVPL,Envoplakin,23825,109,1.78 [1.20-2.63],0.0041137512007032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP1,"Fatty acid-binding protein, liver",27916,132,1.23 [1.06-1.43],0.0076008057135346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP3,"Fatty acid-binding protein, heart",24272,114,1.58 [1.19-2.10],0.0014869545717528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP4,"Fatty acid-binding protein, adipocyte",28281,131,1.58 [1.20-2.09],0.00122084356309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM3C,Protein FAM3C,27906,130,2.30 [1.42-3.73],0.0007119683760297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24272,114,1.36 [1.08-1.72],0.0098321419842941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24236,113,2.29 [1.28-4.11],0.0053758043380677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF21,Fibroblast growth factor 21,28152,131,1.17 [1.04-1.32],0.0080525070660301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF23,Fibroblast growth factor 23,28138,130,1.42 [1.18-1.71],0.0001647394656536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF5,Fibroblast growth factor 5,27416,127,1.83 [1.23-2.71],0.002706693015806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGFR2,Fibroblast growth factor receptor 2,28005,132,3.15 [1.76-5.66],0.0001143836434081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLRT2,Leucine-rich repeat transmembrane protein FLRT2,27748,130,2.50 [1.54-4.07],0.0002019456898187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FNDC1,Fibronectin type III domain-containing protein 1,24203,112,1.72 [1.18-2.52],0.0050976542995997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24157,113,1.70 [1.20-2.41],0.0031233607491319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOLR1,Folate receptor alpha,27872,131,2.19 [1.35-3.56],0.0015920172905328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FSTL1,Follistatin-related protein 1,23595,112,2.82 [1.46-5.44],0.001949106984495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FSTL3,Follistatin-related protein 3,27879,131,2.62 [1.74-3.95],4.077142242909067e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,28203,133,1.63 [1.17-2.26],0.0035739360800629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAST,Gastrin,24203,112,1.28 [1.14-1.43],3.245725969905234e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GBP1,Guanylate-binding protein 1,24158,112,1.42 [1.11-1.83],0.0053642856162163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GBP4,Guanylate-binding protein 4,27277,126,1.44 [1.10-1.89],0.0078474116053533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",27812,130,2.32 [1.53-3.51],7.777733381417718e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GDF15,Growth/differentiation factor 15,28281,131,1.79 [1.47-2.18],9.941940870169773e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GDNF,Glial cell line-derived neurotrophic factor,27277,126,1.68 [1.17-2.43],0.0053846602850103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFRA1,GDNF family receptor alpha-1,28152,131,3.29 [2.02-5.35],1.7903174697875956e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFRA3,GDNF family receptor alpha-3,27656,130,2.02 [1.19-3.42],0.0093486452479888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGH,Gamma-glutamyl hydrolase,27421,130,2.09 [1.45-3.00],7.012578348414355e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGT1,Glutathione hydrolase 1 proenzyme,27879,131,1.51 [1.16-1.96],0.0018908862967903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GM2A,Ganglioside GM2 activator,23692,108,1.55 [1.15-2.10],0.0042100004643417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPR15L,Protein GPR15L,24177,111,1.63 [1.25-2.11],0.0002455306016513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPR37,Prosaposin receptor GPR37,27432,126,1.52 [1.20-1.93],0.0006181618594996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRN,Progranulin,27788,129,2.50 [1.43-4.38],0.0013055922771785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GUCA2A,Guanylin,27796,130,2.22 [1.44-3.41],0.0003042653560469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HAVCR2,Hepatitis A virus cellular receptor 2,27929,131,2.22 [1.51-3.28],5.571578148555289e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HGF,Hepatocyte growth factor,28273,130,2.01 [1.36-2.97],0.0004725779386791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HIP1R,Huntingtin-interacting protein 1-related protein,24165,111,1.50 [1.18-1.90],0.0009262465837793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",27837,130,2.16 [1.48-3.16],7.001023583244343e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HLA-E,"HLA class I histocompatibility antigen, alpha chain E",27925,130,2.58 [1.65-4.04],3.440601452294952e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HNMT,Histamine N-methyltransferase,27615,130,1.57 [1.16-2.13],0.003169053392365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,27708,131,2.67 [1.71-4.17],1.5632794182226847e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HYAL1,Hyaluronidase-1,27750,131,2.30 [1.27-4.16],0.0059311651554228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICAM1,Intercellular adhesion molecule 1,27804,131,3.13 [2.00-4.89],6.061644175841985e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICAM2,Intercellular adhesion molecule 2,28281,131,2.04 [1.24-3.35],0.0051204115789901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICAM3,Intercellular adhesion molecule 3,28281,131,3.26 [1.97-5.37],3.775434043732149e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFI30,Gamma-interferon-inducible lysosomal thiol reductase,23607,109,2.25 [1.54-3.29],2.582052825278772e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNGR1,Interferon gamma receptor 1,28061,132,2.47 [1.50-4.06],0.0003560903879888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNGR2,Interferon gamma receptor 2,27748,130,1.56 [1.19-2.05],0.0011319385115823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNLR1,Interferon lambda receptor 1,27925,130,1.61 [1.19-2.18],0.0019175032209875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGF1R,Insulin-like growth factor 1 receptor,27812,130,2.02 [1.38-2.95],0.000272624754839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,23494,110,1.46 [1.10-1.92],0.0078284815328607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP4,Insulin-like growth factor-binding protein 4,27576,130,1.79 [1.30-2.46],0.0003238575835972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP7,Insulin-like growth factor-binding protein 7,28281,131,2.21 [1.59-3.07],1.992193698781067e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBPL1,Insulin-like growth factor-binding protein-like 1,27938,130,1.84 [1.23-2.73],0.002831728986056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGLC2,Immunoglobulin lambda constant 2,24267,112,1.93 [1.41-2.65],4.340565596716809e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGSF3,Immunoglobulin superfamily member 3,27812,130,1.75 [1.30-2.36],0.000213846668236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL10RB,Interleukin-10 receptor subunit beta,28061,132,2.45 [1.72-3.48],5.731736565074523e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL12A_IL12B,Interleukin-12,27812,130,1.36 [1.13-1.65],0.0015713877381612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL12B,Interleukin-12 subunit beta,28273,130,1.49 [1.13-1.98],0.0050311740374292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL15RA,Interleukin-15 receptor subunit alpha,27416,127,1.99 [1.28-3.10],0.0023939486302947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL18,Interleukin-18,27818,132,1.75 [1.32-2.33],0.0001075834161716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL18BP,Interleukin-18-binding protein,28016,131,2.67 [1.75-4.05],4.568897383753257e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1RN,Interleukin-1 receptor antagonist protein,27866,132,1.36 [1.09-1.71],0.0076689758820991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL22,Interleukin-22,24157,113,1.38 [1.11-1.72],0.0040113223629427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL2RA,Interleukin-2 receptor subunit alpha,27759,131,2.06 [1.49-2.85],1.3654025191803752e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL3RA,Interleukin-3 receptor subunit alpha,27416,127,2.29 [1.50-3.49],0.0001131975993929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL4R,Interleukin-4 receptor subunit alpha,27925,130,2.16 [1.50-3.11],3.6040914019642105e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INHBB,Inhibin beta B chain,23725,107,1.95 [1.41-2.68],4.762304167861354e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INHBC,Inhibin beta C chain,27929,131,1.68 [1.13-2.49],0.0097923105077308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INSR,Insulin receptor,23581,108,5.02 [1.86-13.57],0.0014696446970348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGA5,Integrin alpha-5,27929,131,3.05 [1.73-5.37],0.0001102675554668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB2,Integrin beta-2,27770,129,2.14 [1.34-3.42],0.0014084736455539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB7,Integrin beta-7,28189,131,1.66 [1.23-2.25],0.0009510902203488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGBL1,Integrin beta-like protein 1,24262,111,1.87 [1.26-2.78],0.0019074328332742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24157,113,1.35 [1.11-1.66],0.0033286099766376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLF4,Krueppel-like factor 4,23493,107,1.62 [1.16-2.26],0.0050533313952571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK10,Kallikrein-10,27917,132,1.76 [1.25-2.48],0.0012176839469161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK11,Kallikrein-11,27732,132,2.11 [1.45-3.08],0.0001044195935917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK4,Kallikrein-4,28189,131,1.40 [1.13-1.74],0.0022407764606757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLRB1,Killer cell lectin-like receptor subfamily B member 1,28273,130,2.17 [1.48-3.19],7.069197388232106e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLRD1,Natural killer cells antigen CD94,28273,130,1.75 [1.27-2.42],0.0005978707280789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT19,"Keratin, type I cytoskeletal 19",27887,130,1.39 [1.13-1.72],0.0021845074863547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,27916,132,2.00 [1.57-2.55],1.700396106992002e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMP3,Lysosome-associated membrane glycoprotein 3,28223,128,1.56 [1.17-2.08],0.0025580007599898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAYN,Layilin,27700,130,2.67 [1.82-3.91],5.001113967784752e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LCN15,Lipocalin-15,24236,113,1.43 [1.18-1.74],0.0002558813562669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LECT2,Leukocyte cell-derived chemotaxin-2,24272,114,1.40 [1.11-1.77],0.0043265822896481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS4,Galectin-4,27916,132,1.74 [1.36-2.23],1.1463336762970388e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS9,Galectin-9,27920,132,2.73 [1.79-4.17],2.84166304561227e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,27929,131,2.02 [1.30-3.16],0.0019149409819694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,27906,130,2.34 [1.49-3.66],0.0002089177861493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,28130,131,1.92 [1.21-3.05],0.0057151741047439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,27416,127,2.39 [1.73-3.30],1.2049599782223784e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LMNB2,Lamin-B2,24203,112,2.20 [1.32-3.67],0.0026071224188728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRP11,Low-density lipoprotein receptor-related protein 11,27938,130,1.79 [1.18-2.69],0.0057342489766783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTBP2,Latent-transforming growth factor beta-binding protein 2,28281,131,2.10 [1.34-3.31],0.001327713667953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTBP3,Latent-transforming growth factor beta-binding protein 3,27252,129,1.38 [1.12-1.71],0.002792232741238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTBR,Tumor necrosis factor receptor superfamily member 3,27763,132,2.57 [1.64-4.05],4.39866575622217e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LY6D,Lymphocyte antigen 6D,27767,131,1.70 [1.20-2.40],0.002692141695399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LY9,T-lymphocyte surface antigen Ly-9,27646,125,2.63 [1.59-4.34],0.0001527716560011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LY96,Lymphocyte antigen 96,27748,130,2.08 [1.51-2.85],7.180249776828835e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAMDC2,MAM domain-containing protein 2,24272,114,2.11 [1.32-3.37],0.0018942651138095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MATN2,Matrilin-2,27966,132,2.30 [1.41-3.75],0.0008203093554166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MBL2,Mannose-binding protein C,23952,110,1.29 [1.08-1.53],0.0041578681120637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MILR1,Allergin-1,27416,127,1.68 [1.26-2.23],0.0003697876147569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP12,Macrophage metalloelastase,27981,130,2.01 [1.56-2.59],7.586875095441954e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP13,Collagenase 3,27277,126,1.98 [1.21-3.25],0.0064276356456174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRC1,Macrophage mannose receptor 1,24295,113,2.63 [1.47-4.69],0.0010601115042343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSR1,Macrophage scavenger receptor types I and II,28203,133,1.86 [1.36-2.54],9.845665516479075e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24203,112,2.04 [1.29-3.23],0.0021421239527305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYH7B,Myosin-7B,23409,107,1.54 [1.14-2.07],0.0048566318985574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MZB1,Marginal zone B- and B1-cell-specific protein,28009,132,1.76 [1.34-2.32],5.080085384249122e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NBL1,Neuroblastoma suppressor of tumorigenicity 1,28005,132,2.59 [1.51-4.45],0.0005749604116302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCAN,Neurocan core protein,28203,133,0.42 [0.29-0.62],1.175725601507653e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24177,111,2.84 [1.85-4.37],1.9792839084833427e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCS1,Neuronal calcium sensor 1,28189,131,2.08 [1.23-3.52],0.0065847204551633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NECTIN2,Nectin-2,27906,130,2.69 [1.70-4.24],2.30983542519079e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEFL,Neurofilament light polypeptide,27189,125,2.00 [1.59-2.51],4.135020187249551e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NELL1,Protein kinase C-binding protein NELL1,28005,132,0.61 [0.42-0.87],0.0071289667223241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFASC,Neurofascin,28273,130,2.04 [1.23-3.38],0.0056880497466252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NME3,Nucleoside diphosphate kinase 3,27966,132,2.10 [1.31-3.39],0.0022660387120922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOTCH1,Neurogenic locus notch homolog protein 1,28281,131,3.58 [1.43-8.99],0.006545281637942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPC2,NPC intracellular cholesterol transporter 2,23862,108,2.28 [1.56-3.32],1.8013979508354968e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPDC1,Neural proliferation differentiation and control protein 1,27938,130,1.83 [1.21-2.76],0.004182465447621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPPC,C-type natriuretic peptide,27925,130,1.58 [1.20-2.08],0.001152311440282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NT5C1A,Cytosolic 5'-nucleotidase 1A,24203,112,2.04 [1.54-2.70],7.659540206652176e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OCLN,Occludin,24236,113,2.16 [1.57-2.96],2.0693827161484176e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OGN,Mimecan,27929,131,2.07 [1.46-2.94],4.2990061312352175e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OSCAR,Osteoclast-associated immunoglobulin-like receptor,27966,132,2.96 [1.88-4.67],3.002415787962161e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24236,113,1.18 [1.04-1.33],0.0078226995222238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",23825,109,1.66 [1.25-2.20],0.000520304459508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PALM,Paralemmin-1,24051,111,2.21 [1.38-3.56],0.0010717734971101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PALM2,Paralemmin-2,24203,112,1.77 [1.22-2.58],0.0026097384758064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCDH17,Protocadherin-17,27938,130,1.74 [1.16-2.61],0.0074907750807275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCDHB15,Protocadherin beta-15,24157,113,1.63 [1.14-2.33],0.0069594520151881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDCD1,Programmed cell death protein 1,28147,131,1.84 [1.34-2.52],0.0001426851025934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDCD1LG2,Programmed cell death 1 ligand 2,27812,130,2.07 [1.33-3.23],0.0012545880579152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGF,Placenta growth factor,28273,130,2.09 [1.48-2.94],2.615534768450137e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGLYRP1,Peptidoglycan recognition protein 1,28130,131,1.68 [1.22-2.30],0.0013258166117332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PI3,Elafin,27549,129,1.41 [1.10-1.81],0.0063882767976162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIGR,Polymeric immunoglobulin receptor,27571,131,1.91 [1.31-2.76],0.0006768265386869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,27929,131,2.38 [1.44-3.93],0.0006918771573223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PILRA,Paired immunoglobulin-like type 2 receptor alpha,27929,131,2.01 [1.39-2.90],0.0001861612640225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PILRB,Paired immunoglobulin-like type 2 receptor beta,27938,130,1.75 [1.30-2.35],0.0002131932302836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PKD1,Polycystin-1,24272,114,2.41 [1.25-4.65],0.0090006867112672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G15,Phospholipase A2 group XV,28005,132,2.21 [1.30-3.75],0.0034743119753858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLAUR,Urokinase plasminogen activator surface receptor,27728,132,3.27 [1.99-5.38],3.086482174958563e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLXNB2,Plexin-B2,28149,131,2.92 [1.64-5.17],0.0002521512804704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),POF1B,Protein POF1B,23581,108,1.74 [1.33-2.28],4.721005003166612e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PON1,Serum paraoxonase/arylesterase 1,24295,113,0.47 [0.29-0.77],0.0028967265791367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24236,113,1.62 [1.12-2.35],0.0097322862524026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRAP1,Proline-rich acidic protein 1,24262,111,1.93 [1.22-3.05],0.0048916373996209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRL,Prolactin,28203,133,1.35 [1.13-1.60],0.0007789328644624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PROS1,Vitamin K-dependent protein S,24305,112,0.35 [0.17-0.71],0.00393846534273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRSS8,Prostasin,27826,132,1.77 [1.26-2.49],0.0011064280544237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSAP,Prosaposin,24041,109,2.47 [1.64-3.71],1.3323995275955488e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSG1,Pregnancy-specific beta-1-glycoprotein 1,27748,130,1.32 [1.12-1.55],0.0007319579880848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTGDS,Prostaglandin-H2 D-isomerase,27718,131,2.30 [1.53-3.44],5.614446394285337e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTN,Pleiotrophin,27432,126,1.48 [1.11-1.96],0.0068700017667997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRC,Receptor-type tyrosine-protein phosphatase C,24262,111,2.74 [1.38-5.45],0.0040821541868722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24177,111,2.32 [1.47-3.67],0.0003265157862654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRM,Receptor-type tyrosine-protein phosphatase mu,27873,129,3.21 [1.77-5.83],0.0001278530056033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RARRES2,Retinoic acid receptor responder protein 2,28072,131,1.49 [1.14-1.94],0.0036478410094883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBFOX3,RNA binding protein fox-1 homolog 3,24236,113,1.85 [1.37-2.50],5.288515632195435e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBP7,Retinoid-binding protein 7,24177,111,1.38 [1.09-1.74],0.0069376437738431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG1A,Lithostathine-1-alpha,27772,131,1.56 [1.20-2.03],0.0008012922518299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG1B,Lithostathine-1-beta,28281,131,1.49 [1.20-1.86],0.0003571764246445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG3A,Regenerating islet-derived protein 3-alpha,28281,131,1.46 [1.17-1.83],0.0008468524122712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RELT,Tumor necrosis factor receptor superfamily member 19L,27929,131,2.34 [1.40-3.92],0.0011641861821552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REN,Renin,27938,130,1.51 [1.27-1.78],1.6911696165959822e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RIPK4,Receptor-interacting serine/threonine-protein kinase 4,23494,110,1.35 [1.12-1.62],0.0016217652557091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASE1,Ribonuclease pancreatic,24295,113,3.21 [2.04-5.07],5.240262841409038e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASE4,Ribonuclease 4,23518,111,2.05 [1.20-3.52],0.0090214291762369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASE6,Ribonuclease K6,24122,112,2.38 [1.75-3.23],2.9976631064672854e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASET2,Ribonuclease T2,28135,129,2.32 [1.40-3.86],0.0011179141054024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF149,E3 ubiquitin-protein ligase RNF149,23595,112,2.21 [1.30-3.76],0.0035563945150053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ROBO1,Roundabout homolog 1,27966,132,3.54 [2.08-6.02],3.2954682240879906e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAT2,Thialysine N-epsilon-acetyltransferase,23825,109,1.32 [1.10-1.58],0.0033046010370518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARA5,Scavenger receptor class A member 5,28203,133,1.97 [1.19-3.25],0.0082627367462056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARB2,Lysosome membrane protein 2,27214,127,2.53 [1.66-3.85],1.5998072697912426e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARF2,Scavenger receptor class F member 2,28203,133,2.28 [1.35-3.85],0.0021787918116835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCRG1,Scrapie-responsive protein 1,24272,114,2.06 [1.38-3.07],0.0003912289655021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SDC1,Syndecan-1,27938,130,1.62 [1.19-2.22],0.0024780610598966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SELENOP,Selenoprotein P,24305,112,0.48 [0.27-0.83],0.009177261592657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEMA7A,Semaphorin-7A,28182,131,2.14 [1.36-3.36],0.0010399016534539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SFRP1,Secreted frizzled-related protein 1,27649,130,1.59 [1.19-2.12],0.0016913847323988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHISA5,Protein shisa-5,24262,111,2.50 [1.56-3.99],0.0001362590125515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC1,Sialoadhesin,28061,132,1.68 [1.20-2.35],0.0025941904384011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC10,Sialic acid-binding Ig-like lectin 10,27925,130,2.13 [1.42-3.18],0.000245998990918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC6,Sialic acid-binding Ig-like lectin 6,28189,131,1.86 [1.24-2.78],0.0027264360688251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC7,Sialic acid-binding Ig-like lectin 7,27938,130,2.71 [1.66-4.42],6.570594562888693e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIRPB1,Signal-regulatory protein beta-1,27861,132,1.74 [1.25-2.42],0.0009869178833028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLAMF1,Signaling lymphocytic activation molecule,27416,127,1.67 [1.29-2.16],8.930465798128255e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLAMF7,SLAM family member 7,27925,130,1.42 [1.11-1.83],0.005978480554494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SORCS2,VPS10 domain-containing receptor SorCS2,27252,129,2.00 [1.35-2.96],0.0005638857082438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK1,Serine protease inhibitor Kazal-type 1,27929,131,1.71 [1.26-2.30],0.0004936613824709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINT1,Kunitz-type protease inhibitor 1,27830,131,2.40 [1.55-3.73],9.56446914454059e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPON1,Spondin-1,27966,132,2.24 [1.50-3.35],7.730828859589618e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPON2,Spondin-2,27804,130,2.83 [1.87-4.26],7.130078957911359e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPP1,Osteopontin,28229,131,1.66 [1.21-2.29],0.0017730062713661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SRPX,Sushi repeat-containing protein SRPX,24272,114,2.00 [1.20-3.30],0.0073138206974961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STAU1,Double-stranded RNA-binding protein Staufen homolog 1,23409,107,1.38 [1.12-1.71],0.0029125776159315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STC1,Stanniocalcin-1,28203,133,1.60 [1.16-2.19],0.003719496886285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SV2A,Synaptic vesicle glycoprotein 2A,23599,110,1.43 [1.13-1.81],0.0027808610722715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TAFA5,Chemokine-like protein TAFA-5,27812,130,2.17 [1.48-3.18],7.016201496083114e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCN2,Transcobalamin-2,28229,131,2.34 [1.63-3.36],3.864963717695914e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TEX33,Testis-expressed protein 33,23825,109,1.49 [1.11-1.99],0.0076677610859574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFF1,Trefoil factor 1,27797,131,1.27 [1.07-1.52],0.0067750458501728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFF2,Trefoil factor 2,28018,132,1.52 [1.21-1.92],0.0003890404870788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFA,Protransforming growth factor alpha,27925,130,1.70 [1.28-2.25],0.0002307765057368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFBR2,TGF-beta receptor type-2,28005,132,2.02 [1.37-2.99],0.0004119837188319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGOLN2,Trans-Golgi network integral membrane protein 2,24295,113,3.28 [1.78-6.04],0.0001401010894471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THBS2,Thrombospondin-2,27929,131,1.89 [1.36-2.61],0.0001233157425426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMP1,Metalloproteinase inhibitor 1,27607,130,2.38 [1.51-3.74],0.0001777557007643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMP4,Metalloproteinase inhibitor 4,27929,131,1.75 [1.24-2.47],0.0014959963279415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TLR2,Toll-like receptor 2,23825,109,3.48 [1.74-6.93],0.0004061880832531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMPRSS11D,Transmembrane protease serine 11D,24147,110,2.16 [1.48-3.15],5.924638116993745e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNC,Tenascin,28016,131,1.56 [1.15-2.13],0.0041600040681651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNF,Tumor necrosis factor,27383,126,1.49 [1.15-1.93],0.0028193963726657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,27748,130,2.35 [1.77-3.13],4.880111645542309e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,27748,130,1.39 [1.18-1.65],0.0001091428528315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,28273,130,2.02 [1.43-2.86],7.382381916239651e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,27916,132,2.21 [1.41-3.45],0.0004939221985102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,28005,132,2.08 [1.42-3.05],0.0001821765527851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,27966,132,2.05 [1.47-2.87],2.563431968448332e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF14,Tumor necrosis factor receptor superfamily member 14,27966,132,2.47 [1.59-3.83],5.511634248254411e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF19,Tumor necrosis factor receptor superfamily member 19,28189,131,2.28 [1.56-3.32],2.008667936211606e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,27929,131,2.98 [1.91-4.64],1.492235982172402e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,27929,131,1.78 [1.44-2.20],9.865671565166373e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF4,Tumor necrosis factor receptor superfamily member 4,28223,128,2.48 [1.81-3.38],1.1132567834278058e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,27748,130,1.45 [1.13-1.85],0.0030156960674261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF8,Tumor necrosis factor receptor superfamily member 8,28203,133,1.56 [1.16-2.11],0.0036450925910317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF9,Tumor necrosis factor receptor superfamily member 9,27748,130,2.00 [1.53-2.61],3.00594604048457e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,28228,131,3.23 [2.19-4.77],3.355843964404062e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF8,Tumor necrosis factor ligand superfamily member 8,24262,111,2.06 [1.35-3.16],0.0008279467688015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TREM2,Triggering receptor expressed on myeloid cells 2,27916,132,1.62 [1.25-2.11],0.0003125744209094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXNDC15,Thioredoxin domain-containing protein 15,28005,132,1.97 [1.18-3.29],0.0096452628712225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ULBP2,UL16-binding protein 2,27748,130,2.15 [1.50-3.09],3.5150610631065054e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UXS1,UDP-glucuronic acid decarboxylase 1,27252,129,1.40 [1.12-1.76],0.0034861049800439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VCAM1,Vascular cell adhesion protein 1,27982,131,2.37 [1.42-3.97],0.0009998032482564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VCAN,Versican core protein,28203,133,2.01 [1.23-3.28],0.0055856371277029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VEGFB,Vascular endothelial growth factor B,23581,108,2.45 [1.39-4.31],0.0019093526446948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VNN2,Vascular non-inflammatory molecule 2,27812,130,1.68 [1.18-2.41],0.004420138869802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,23494,110,2.19 [1.58-3.05],3.249299003220324e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIG2,V-set and immunoglobulin domain-containing protein 2,24157,113,1.90 [1.50-2.41],1.195758194512397e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIG4,V-set and immunoglobulin domain-containing protein 4,27891,131,2.49 [1.81-3.43],2.3804593843525185e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VWC2,Brorin,27652,130,1.92 [1.31-2.83],0.0008472282348961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WASF3,Wiskott-Aldrich syndrome protein family member 3,27277,126,0.79 [0.67-0.93],0.0042176275372369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WFDC2,WAP four-disulfide core domain protein 2,26492,124,2.69 [2.01-3.59],2.0553070453566896e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WNT9A,Protein Wnt-9a,27416,127,2.07 [1.37-3.13],0.0005683188247787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YAP1,Transcriptional coactivator YAP1,24203,112,2.41 [1.43-4.05],0.0009507998606639
